Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material

Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material Type, Application - Global Forecast 2023-2030


The Biopharmaceuticals Market size was estimated at USD 525.70 billion in 2022 and expected to reach USD 574.04 billion in 2023, at a CAGR 9.67% to reach USD 1,100.51 billion by 2030.

Biopharmaceuticals, also known as biologics, refer to medical drugs produced using biotechnology. They are comprised of proteins and nucleic acids and are used for therapeutic or diagnostic purposes. Unlike traditional pharmaceuticals, which are chemically synthesized and have well-defined molecular structures, biopharmaceuticals are derived from living organisms. These organisms can include bacteria, yeast, or mammalian cells that are genetically engineered to produce the desired therapeutic substances, such as hormones, antibodies, or vaccines. The rising incidences of chronic and infectious diseases such as cancer, cardiovascular disorders, tuberculosis, Crohn's disease, and arthritis have created a need for novel biopharmaceuticals. Additionally, the expansion of healthcare infrastructure, growing access to healthcare services, and supportive government initiatives that promote the discovery and development of new pharmaceuticals have further generated growth for the industry. However, maintaining cold chain logistics for temperature-sensitive products can prove to be a hurdle for biopharmaceuticals. Furthermore, complexities in manufacturing processes can also significantly impede the widespread growth of the industry. However, key players are investing in new technologies such as AI/ML and data analytics to streamline and accelerate the production of biopharmaceuticals. Moreover, the adoption of personalized medicine and advancement in genomic research can create new opportunities for the growth of the industry.

Regional Insights

The Americas region, particularly the U.S. and Canada, remains a highly advanced region in biopharmaceutical research and development, spurred by a combination of robust intellectual property rights, a science-driven regulatory framework, and a competitive market landscape. The U.S. Food and Drug Administration (FDA) continuously adapts to the rapid pace of innovation, ensuring safe and effective treatments reach patients. The presence of several key players in the biotechnological sector and a robust healthcare infrastructure that provides reimbursements and health insurance have led to the growth of the biopharmaceutical industry. The EU region boasts a robust ground for research and development in the sphere of life sciences and biotechnology. Stringent regulations and standards pertaining to the development of biopharmaceuticals have created a standardized, systematic, and safe environment for innovations in biopharmaceuticals. The European Medicines Agency (EMA) in the EU plays a central role in facilitating the development and accessibility of new therapies. Strong public-private partnerships and a commitment to healthcare innovation define the EU's consumer needs and behavior, which lean towards high-quality, sustainable healthcare solutions. In the APAC region, a growing aging population and government incentives and initiatives for promoting access to affordable healthcare services have led to a need for biopharmaceuticals. Japan, with its established pharmaceutical sector, is characterized by significant spending on healthcare solutions. Countries in the APAC region, such as India and China, have focused on the cost-effective manufacturing of biopharmaceuticals and often invest in biosimilar production.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Abgenex, Amgen Inc., AstraZeneca PLC, Avidea Technologies, Bayer AG, Bio-Techne Corporation, Biogen Inc., bioMérieux SA, Bristol-Myers Squibb Company, BTL Biotechno Labs Pvt. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Ferring Pharmaceuticals, GlaxoSmithKline PLC, Ipsen Pharma, Johnson & Johnson Services, Inc., LG Chem Life Sciences Innovation Center, Inc., Merck & Co., Inc., Nordic BioSite, Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type

Monoclonal Antibodies
  • Purified Proteins
  • Recombinant Growth Factors
  • Recombinant Hormone
  • Recombinant Proteins
  • Synthetic Immunomodulators
  • Vaccines
  • Services

    Compendial & Multi Compendial Laboratory Testing
  • Custom Testing or Customer Proprietary Testing
  • Laboratory Testing
  • Raw Material Type

    Active Pharmaceutical Ingredient
  • Formulation Excipients
  • Application

    Autoimmune Disorders
  • Cardiovascular Diseases
  • Hormonal Disorders
  • Immunology
  • Inflammatory & Infectious Diseases
  • Metabolic Disorders
  • Neurological Diseases
  • Oncology

    Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

    The report offers valuable insights on the following aspects:
    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:
    1. What is the market size and forecast of the Biopharmaceuticals Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopharmaceuticals Market?
    3. What are the technology trends and regulatory frameworks in the Biopharmaceuticals Market?
    4. What is the market share of the leading vendors in the Biopharmaceuticals Market?
    5. Which modes and strategic moves are suitable for entering the Biopharmaceuticals Market?


    Please Note: PDF & Excel + Online Access - 1 Year

  • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Biopharmaceuticals Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Prevalence of Chronic Diseases and Need for Targeted Biopharmaceuticals
    5.1.1.2. Rising Investments in Vaccine and Drugs Development
    5.1.1.3. Attractive Reimbursement Policies for Biopharmaceuticals
    5.1.2. Restraints
    5.1.2.1. Raw Material Supply Chain Disruptions and High Cost of Drug Development
    5.1.3. Opportunities
    5.1.3.1. Advancements in Biopharmaceutical Manufacturing and Testing Technologies
    5.1.3.2. Emerging Trends of Outsourcing Biologics and Vaccine Manufacturing
    5.1.4. Challenges
    5.1.4.1. Stringent Regulatory Framework for Drug Manufacturing and Time-Consuming Clinical Trials
    5.2. Market Segmentation Analysis
    5.2.1. Product Type: Ongoing R&D initiatives to promote innovations in the field of monoclonal antibodies
    5.2.2. Services: Need for compendial & multi compendial laboratory testing to ensure compliance with regulations
    5.2.3. Raw Material Type: Efforts to develop potent APIs to diagnose, cure, or mitigate disease conditions
    5.2.4. Application: Changes in lifestyles leading to the need for treatment strategies for cardiovascular diseases
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of COVID-19
    5.5. Cumulative Impact of Russia-Ukraine Conflict
    5.6. Cumulative Impact of High Inflation
    5.7. Porter’s Five Forces Analysis
    5.7.1. Threat of New Entrants
    5.7.2. Threat of Substitutes
    5.7.3. Bargaining Power of Customers
    5.7.4. Bargaining Power of Suppliers
    5.7.5. Industry Rivalry
    5.8. Value Chain & Critical Path Analysis
    5.9. Regulatory Framework
    5.10. Client Customization
    6. Biopharmaceuticals Market, by Product Type
    6.1. Introduction
    6.2. Monoclonal Antibodies
    6.3. Purified Proteins
    6.4. Recombinant Growth Factors
    6.5. Recombinant Hormone
    6.6. Recombinant Proteins
    6.7. Synthetic Immunomodulators
    6.8. Vaccines
    7. Biopharmaceuticals Market, by Services
    7.1. Introduction
    7.2. Compendial & Multi Compendial Laboratory Testing
    7.3. Custom Testing or Customer Proprietary Testing
    7.4. Laboratory Testing
    8. Biopharmaceuticals Market, by Raw Material Type
    8.1. Introduction
    8.2. Active Pharmaceutical Ingredient
    8.3. Formulation Excipients
    9. Biopharmaceuticals Market, by Application
    9.1. Introduction
    9.2. Autoimmune Disorders
    9.3. Cardiovascular Diseases
    9.4. Hormonal Disorders
    9.5. Immunology
    9.6. Inflammatory & Infectious Diseases
    9.7. Metabolic Disorders
    9.8. Neurological Diseases
    9.9. Oncology
    10. Americas Biopharmaceuticals Market
    10.1. Introduction
    10.2. Argentina
    10.3. Brazil
    10.4. Canada
    10.5. Mexico
    10.6. United States
    11. Asia-Pacific Biopharmaceuticals Market
    11.1. Introduction
    11.2. Australia
    11.3. China
    11.4. India
    11.5. Indonesia
    11.6. Japan
    11.7. Malaysia
    11.8. Philippines
    11.9. Singapore
    11.10. South Korea
    11.11. Taiwan
    11.12. Thailand
    11.13. Vietnam
    12. Europe, Middle East & Africa Biopharmaceuticals Market
    12.1. Introduction
    12.2. Denmark
    12.3. Egypt
    12.4. Finland
    12.5. France
    12.6. Germany
    12.7. Israel
    12.8. Italy
    12.9. Netherlands
    12.10. Nigeria
    12.11. Norway
    12.12. Poland
    12.13. Qatar
    12.14. Russia
    12.15. Saudi Arabia
    12.16. South Africa
    12.17. Spain
    12.18. Sweden
    12.19. Switzerland
    12.20. Turkey
    12.21. United Arab Emirates
    12.22. United Kingdom
    13. Competitive Landscape
    13.1. FPNV Positioning Matrix
    13.2. Market Share Analysis, By Key Player
    13.3. Competitive Scenario Analysis, By Key Player
    13.3.1. Merger & Acquisition
    13.3.1.1. AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
    13.3.2. Agreement, Collaboration, & Partnership
    13.3.2.1. HHS Announces Details of Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies
    13.3.3. New Product Launch & Enhancement
    13.3.3.1. LEQEMBI Intravenous Infusion (Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20
    14. Competitive Portfolio
    14.1. Key Company Profiles
    14.1.1. Abbott Laboratories
    14.1.2. AbbVie Inc.
    14.1.3. Abgenex
    14.1.4. Amgen Inc.
    14.1.5. AstraZeneca PLC
    14.1.6. Avidea Technologies
    14.1.7. Bayer AG
    14.1.8. Bio-Techne Corporation
    14.1.9. Biogen Inc.
    14.1.10. bioMérieux SA
    14.1.11. Bristol-Myers Squibb Company
    14.1.12. BTL Biotechno Labs Pvt. Ltd.
    14.1.13. Eli Lilly and Company
    14.1.14. F. Hoffmann-La Roche AG
    14.1.15. Ferring Pharmaceuticals
    14.1.16. GlaxoSmithKline PLC
    14.1.17. Ipsen Pharma
    14.1.18. Johnson & Johnson Services, Inc.
    14.1.19. LG Chem Life Sciences Innovation Center, Inc.
    14.1.20. Merck & Co., Inc.
    14.1.21. Nordic BioSite
    14.1.22. Novartis AG
    14.1.23. Novo Nordisk A/S
    14.1.24. Pfizer, Inc.
    14.1.25. Sanofi S.A.
    14.1.26. Takeda Pharmaceutical Company Limited
    14.1.27. Thermo Fisher Scientific Inc.
    14.2. Key Product Portfolio
    15. Appendix
    15.1. Discussion Guide
    15.2. License & Pricing
    FIGURE 1. BIOPHARMACEUTICALS MARKET RESEARCH PROCESS
    FIGURE 2. BIOPHARMACEUTICALS MARKET SIZE, 2022 VS 2030
    FIGURE 3. BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
    FIGURE 5. BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 6. BIOPHARMACEUTICALS MARKET DYNAMICS
    FIGURE 7. BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
    FIGURE 8. BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 9. BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
    FIGURE 10. BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 11. BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2022 VS 2030 (%)
    FIGURE 12. BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 13. BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
    FIGURE 14. BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 15. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
    FIGURE 16. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 17. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
    FIGURE 18. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
    FIGURE 20. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
    FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
    FIGURE 23. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
    FIGURE 24. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022
    TABLE 1. BIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
    TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
    TABLE 3. BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
    TABLE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
    TABLE 5. BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 6. BIOPHARMACEUTICALS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
    TABLE 7. BIOPHARMACEUTICALS MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 8. BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 9. BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT HORMONE, BY REGION, 2018-2030 (USD MILLION)
    TABLE 10. BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 11. BIOPHARMACEUTICALS MARKET SIZE, BY SYNTHETIC IMMUNOMODULATORS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 12. BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
    TABLE 13. BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 14. BIOPHARMACEUTICALS MARKET SIZE, BY COMPENDIAL & MULTI COMPENDIAL LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
    TABLE 15. BIOPHARMACEUTICALS MARKET SIZE, BY CUSTOM TESTING OR CUSTOMER PROPRIETARY TESTING, BY REGION, 2018-2030 (USD MILLION)
    TABLE 16. BIOPHARMACEUTICALS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
    TABLE 17. BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 18. BIOPHARMACEUTICALS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
    TABLE 19. BIOPHARMACEUTICALS MARKET SIZE, BY FORMULATION EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 20. BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 21. BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 22. BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
    TABLE 23. BIOPHARMACEUTICALS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 24. BIOPHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
    TABLE 25. BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
    TABLE 26. BIOPHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
    TABLE 27. BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
    TABLE 28. BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
    TABLE 29. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 30. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 31. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 32. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 33. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    TABLE 34. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 35. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 36. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 37. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 38. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 39. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 40. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 41. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 42. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 43. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 44. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 45. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 46. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 47. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 48. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 49. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 50. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 51. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 52. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 53. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 54. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
    TABLE 55. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 56. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 57. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 58. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 59. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    TABLE 60. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 61. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 62. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 63. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 64. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 65. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 66. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 67. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 68. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 69. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 70. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 71. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 72. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 73. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 74. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 75. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 76. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 77. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 78. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 79. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 80. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 81. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 82. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 83. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 84. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 85. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 86. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 87. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 88. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 89. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 90. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 91. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 92. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 93. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 94. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 95. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 96. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 97. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 98. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 99. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 100. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 101. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 102. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 103. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 104. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 105. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 106. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 107. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    TABLE 113. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 114. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 115. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 116. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 117. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 118. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 119. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 120. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 121. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 122. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 123. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 124. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 125. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 126. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 127. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 128. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 129. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 130. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 131. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 132. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 133. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 134. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 135. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 136. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 137. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 138. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 139. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 140. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 141. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 142. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 143. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 144. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 145. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 146. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 147. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 148. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 149. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 150. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 151. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 152. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 153. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 154. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 155. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 156. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 157. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 158. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 159. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 160. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 161. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 162. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 163. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 164. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 165. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 166. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 167. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 168. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 169. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 170. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 171. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 172. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 173. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 174. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 175. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 176. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 177. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 178. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 179. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 180. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 181. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 182. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 183. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 184. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 185. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 186. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 187. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 188. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 189. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 190. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 191. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 192. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 193. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
    TABLE 194. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
    TABLE 195. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
    TABLE 196. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    TABLE 197. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
    TABLE 198. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022
    TABLE 199. BIOPHARMACEUTICALS MARKET LICENSE & PRICING

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings